Search

Gregory Bleck Phones & Addresses

  • 620 Clear Spring Ct, Madison, WI 53716
  • Monona, WI
  • 620 Clear Spring Ct, Monona, WI 53716 (608) 222-2698

Work

Position: Machine Operators, Assemblers, and Inspectors Occupations

Education

Degree: High school graduate or higher

Resumes

Resumes

Gregory Bleck Photo 1

Owner And Photographic Artist

View page
Location:
620 Clear Spring Ct, Monona, WI 53716
Industry:
Photography
Work:
TinTypes Today - Madison, Wisconsin Area since Jun 2013
Owner / Photographic Artist
Education:
Madison Area Technical College
Associate's Degree Visual Communication & Associate's Degree in Liberal Studies, Photography & Liberal Studies.
Professional Photographers Of America
Master of Photography
Skills:
Photography
Digital Photography
Portrait Photography
Photoshop
Commercial Photography
Portraits
Event Photography
Wedding Photography
Fine Art Photography
Photojournalism
Graphic Design
Photos
Image Manipulation
Image Editing
Headshots
Fashion Photography
Weddings
Video
Lightroom
Art
Social Media
Customer Service
Lifestyle Photography
Studio Photography
Senior Portraits
Interests:
Teaching
Gregorian Chant
Canoeing
Gardening
Historic Photographic Processes
Latin
Reading (Poetry and Theology)
See Less
Prayer and Meditation
Biking
Music
Playing Congas
Working With the Disabled
See 2
Gregory Bleck Photo 2

Gregory Bleck

View page
Location:
Madison, WI
Industry:
Biotechnology
Gregory Bleck Photo 3

Gregory Bleck

View page

Publications

Us Patents

Expression Vectors

View page
US Patent:
7378273, May 27, 2008
Filed:
Sep 23, 2004
Appl. No.:
10/947881
Inventors:
Gregory T. Bleck - Baraboo WI, US
Assignee:
Gala Design, Inc. - Middleton WI
International Classification:
C12N 5/00
C07H 21/04
A01N 63/00
C12P 21/06
US Classification:
4353201, 435325, 435 691, 536 241, 424 932
Abstract:
The present invention provides novel regulatory elements and vectors for the expression of one or more proteins in a host cell. The present invention also provides methods for expressing one or more proteins, such as antibodies, in a host cell. These methods utilize the novel regulatory elements and vectors of the present invention for the expression of proteins in a host cell. The host cells are used for producing various protein products, including but not limited to pharmaceutical proteins, antibodies, variants of proteins for use in screening assays, and for direct use in high throughput screening.

Fusion Antibodies

View page
US Patent:
7696322, Apr 13, 2010
Filed:
Jul 28, 2004
Appl. No.:
10/900928
Inventors:
Gregory T. Bleck - Cross Plains WI, US
Dona York - Wisconsin Dells WI, US
Ian Collins - Prairie du Sac WI, US
Assignee:
Catalent Pharma Solutions, Inc. - Somerset NJ
International Classification:
C12P 21/08
C07K 16/00
A61K 39/395
C12P 21/04
C07H 21/04
US Classification:
5303873, 4241331, 4241361, 4241411, 435 696, 435 7021, 5303881
Abstract:
The present invention provides novel antibodies. In particular, the present invention provides fusion antibodies comprising antibody heavy and light chain fusions. The present invention further provides multivalent antibodies comprising multiple fusion antibody chains. The present invention further provides methods of generating splice resistant antibody genes.

Rage Fusion Proteins

View page
US Patent:
8398977, Mar 19, 2013
Filed:
Jun 13, 2008
Appl. No.:
12/664111
Inventors:
Gregory T. Bleck - Cross Plains WI, US
David M. Hilbert - Bethesda MD, US
Assignee:
Galactica Pharmaceuticals, Inc. - Villanova PA
International Classification:
A61K 39/395
C12P 21/04
US Classification:
4241341, 5303873
Abstract:
The present invention provides novel therapeutics and methods of treatment for diseases associated with activation of the advanced glycation endproducts receptor (RAGE).

Expression Vectors

View page
US Patent:
20020106729, Aug 8, 2002
Filed:
Jun 29, 2001
Appl. No.:
09/897006
Inventors:
Gregory Bleck - Baraboo WI, US
International Classification:
C12P021/02
C12N005/06
C12N015/867
C12Q001/68
C07H021/04
US Classification:
435/069100, 435/456000, 435/320100, 435/325000, 536/023200, 435/006000
Abstract:
The present invention provides novel regulatory elements and vectors for the expression of one or more proteins in a host cell. The present invention also provides methods for expressing one or more proteins, such as antibodies, in a host cell. These methods utilize the novel regulatory elements and vectors of the present invention for the expression of proteins in a host cell. The host cells are used for producing various protein products, including but not limited to pharmaceutical proteins, antibodies, variants of proteins for use in screening assays, and for direct use in high throughput screening.

Fatty Liver Disease Resistant Bovines

View page
US Patent:
20040088744, May 6, 2004
Filed:
Sep 22, 2003
Appl. No.:
10/344115
Inventors:
Alan Attie - Madison WI, US
Gregory Bleck - Cross Plains WI, US
Robert Bremel - Hillpoint WI, US
Jane Homan - Hillpoint WI, US
International Classification:
A01K067/027
US Classification:
800/015000
Abstract:
The present invention provides methods for the production of a transgenic bovine. In particular, the present invention provides methods for generating transgenic bovines with transgenes that enhance the ability of the bovines to metabolize lipids. The present invention thus provides bovines resistant to fatty liver disease. The compositions and methods of the present invention provide a solution to costly disease.

Production Of Host Cells Containing Multiple Integrating Vectors By Serial Transduction

View page
US Patent:
20040235173, Nov 25, 2004
Filed:
Jan 16, 2004
Appl. No.:
10/759315
Inventors:
Gregory Bleck - Cross Plains WI, US
Robert Bremel - Hillpoint WI, US
Linda Miller - Lodi WI, US
Assignee:
Gala Design, Inc. - Middleton WI
International Classification:
C12N015/867
US Classification:
435/456000
Abstract:
The present invention relates to the production of proteins in host cells, and more particularly to host cells containing multiple integrated copies of an integrating vector comprising an exogenous gene and methods of making such host cells by serial transduction or transfection. The present invention further provides methods of expressing increased levels of protein in host cells using such vectors.

Host Cells Containing Multiple Integrating Vectors Comprising An Amplifiable Marker

View page
US Patent:
20050221429, Oct 6, 2005
Filed:
Jan 14, 2005
Appl. No.:
11/036557
Inventors:
Gregory Bleck - Cross Plains WI, US
Assignee:
Cardinal Health PTS, LLC - Dublin OH
International Classification:
C07K016/18
C12N015/867
C07H021/04
C12N005/06
US Classification:
435069100, 435456000, 435326000, 530388100, 536023530
Abstract:
The present invention relates to the production of proteins in host cells, and more particularly to host cells containing multiple integrated copies of an integrating vector comprising an exogenous gene and an amplifiable marker. The present invention further relates to the use of integrating vectors comprising an amplifiable marker. The present invention further provides methods of expressing increased levels of protein in host cells using such vectors.

Fusion Antibodies

View page
US Patent:
20100227394, Sep 9, 2010
Filed:
Mar 9, 2010
Appl. No.:
12/720108
Inventors:
Gregory T. Bleck - Cross Plains WI, US
Dona York - Wisconsin Dells WI, US
Ian Collins - Prairie du Sac WI, US
Assignee:
CATALENT PHARMA SOLUTIONS, INC. - Somerset NJ
International Classification:
C12N 5/071
C07K 16/00
C07H 21/00
C12N 15/74
US Classification:
435325, 5303873, 536 2353, 4353201
Abstract:
The present invention provides novel antibodies. In particular, the present invention provides fusion antibodies comprising antibody heavy and light chain fusions. The present invention further provides multivalent antibodies comprising multiple fusion antibody chains. The present invention further provides methods of generating splice resistant antibody genes.
Gregory R Bleck from Monona, WI, age ~71 Get Report